Health Condition 1: C51-C58- Malignant neoplasms of female genital organs
Conditions
Interventions
Intervention1: Ferric carboxymaltose injection: it is single dose of parenteral intravenous ferric carboxy maltose 15 mg/kg is given in 250 ml normal saline over 15 minutes
Control Intervention1: conv
Sponsors
AAZPIRE
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with gynaecological cancer scheduled for curative surgery.Age between 18-70 years.Screening Preoperative hemoglobin level between 8 gm/dL and 12 gm/dL.Iron profiling study diagnostic of iron deficiency anemia.Eastern Cooperative Oncology Group Score 0-1.Normal renal function tests and liver function test.Written informed consent
Exclusion criteria
Exclusion criteria: Known hypersensitivity or allergy to parenteral iron injections.HO of bleeding disorders, coagulopathy or thromboembolic events.HO of myocardial infarction within last one year or unstable angina or severe coronary disease.Administration of iron supplementation or blood transfusion within the last 3 months of date of enrollment.Ho Thalassemia and Vitamin B12 deficiency.hb less than 8 and greter than 12
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of RBC transfusions between day of OPD registration to post operative day 28Timepoint: Initial day of OPD registration to post operation day 28 | — |
Secondary
| Measure | Time frame |
|---|---|
| cbc levelTimepoint: preop day, post op day 1 , post op day 28;adverse eventsTimepoint: within 2 hours of transfusion | — |
Countries
India
Contacts
Public ContactKarthik Chandra Bassetty
Dr. Bhubaneswar Borooah Cancer Institute
Outcome results
None listed